Identification
- Composition (DCI)
- palipéridone
- Manufacturer
- MAPHAR
- ATC code
- N05AX13
- Presentation
- Boite d'une seringue pré-remplie et 2 aiguilles
- Schedule / Reimb.
- A
- Hospital price
- 7200.00 MAD
Indications
Trevicta, une forme galénique injectable trimestrielle de palmitate de palipéridone, est indiqué dans le traitement de la schizophrénie chez les patients adultes traités depuis au moins quatre mois de manière appropriée avec la forme galénique injectable mensuelle de palmitate de palipéridone.
Find an open pharmacy
On-call pharmacies near you
About TREVICTA 263 MG
TREVICTA 263 MG is marketed in Morocco by MAPHAR and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of TREVICTA 263 MG, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about TREVICTA 263 MG
Answers to common questions from Moroccan patients about this drug.